We recalculated the Selectivity Scores for only MYCN amplified TP53 wild-type neuroblastoma cell lines—representative of high-risk disease—where CX-5461 was the #1 most selective compound for these cell lines (Fig. S1E, S1F). This evidence concerns the gene MYCN and neuroblastoma.